| scholarly article | Q13442814 |
| P50 | author | Francesco Marincola | Q107723823 |
| P2093 | author name string | Rong-Fu Wang | |
| Adam I Riker | |||
| Helen Y Wang | |||
| Juhua Zhou | |||
| Kuichun Zhu | |||
| P2860 | cites work | Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells | Q36369960 |
| A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. | Q36380492 | ||
| CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice | Q36401263 | ||
| The central role of CD4(+) T cells in the antitumor immune response | Q36401381 | ||
| Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice | Q36456716 | ||
| Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules | Q36456744 | ||
| Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15. | Q38299773 | ||
| A large glycoprotein lost from the surfaces of transformed cells | Q39811315 | ||
| Tumor antigens recognized by T lymphocytes | Q40661131 | ||
| Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease | Q40781851 | ||
| Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma | Q40898769 | ||
| CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase | Q41069718 | ||
| Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells | Q41740694 | ||
| CD4 T cells and their role in antitumor immune responses | Q41812728 | ||
| The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses | Q41870329 | ||
| Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors | Q42029476 | ||
| Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin | Q71545599 | ||
| Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes | Q24647904 | ||
| Genomic analysis of metastasis reveals an essential role for RhoC | Q28144278 | ||
| A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames | Q28284379 | ||
| A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma | Q28296086 | ||
| A unique tumor antigen produced by a single amino acid substitution | Q28512841 | ||
| Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin | Q29617865 | ||
| Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells | Q30442808 | ||
| Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells | Q30454278 | ||
| Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen | Q30634368 | ||
| Human tumor antigens for cancer vaccine development | Q33776127 | ||
| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry | Q33874221 | ||
| Immunity against cancer: lessons learned from melanoma. | Q34167925 | ||
| The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity | Q34232543 | ||
| Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA | Q34353749 | ||
| Isolation and characterization of cDNA clones for human and bovine fibronectins | Q34708394 | ||
| CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production | Q35048637 | ||
| The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein | Q35049933 | ||
| CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma | Q35558644 | ||
| The fibronectin receptor is organized by extracellular matrix fibronectin: implications for oncogenic transformation and for cell recognition of fibronectin matrices | Q36220749 | ||
| A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes | Q36365851 | ||
| Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes | Q36366680 | ||
| Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes | Q36367841 | ||
| Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. | Q36367846 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular matrix | Q193825 |
| tumor metastasis | Q120912381 | ||
| P304 | page(s) | 1397-1406 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis | |
| P478 | volume | 195 |
| Q36889067 | Cancer immunotherapy targeting neoantigens |
| Q31037295 | Detection of HLA class II-dependent T helper antigen using antigen phage display. |
| Q37139813 | Enhancing Cancer Immunotherapy by Intracellular Delivery of Cell-Penetrating Peptides and Stimulation of Pattern-Recognition Receptor Signaling |
| Q35005930 | Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens |
| Q35628806 | Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells |
| Q39057617 | Immune targets and neoantigens for cancer immunotherapy and precision medicine |
| Q36402716 | Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors |
| Q24321856 | Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma |
| Q49432766 | Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy. |
| Q30884856 | Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules |
| Q38572896 | Tumor-associated galectin-3 modulates the function of tumor-reactive T cells |
| Q45871925 | Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy |
| Q38084383 | Vaccines against advanced melanoma |
Search more.